The studies involving ThermoDox, Celsion's phase III heat-activated liposomal encapsulation of doxorubicin, are being conducted at the University of Washington School of Medicine by director of endoscopic research Dr. Joo Ha Hwang, PhD. Celsion is supporting the research by contributing ThermoDox supplies, while the Focused Ultrasound Foundation is funding a preclinical study.